{
  "pmcid": "3528899",
  "sha256": "efbd3de14ec9ef5e8ec7c9655084e489a763ed5fe20564c71d310e233760fdc7",
  "timestamp_utc": "2025-11-09T22:37:15.289252+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.179555555555556,
    "reading_ease": 17.05969230769236,
    "word_count": 225
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Intraosseous Versus Systemic Administration of Cefazolin in Primary Total Knee Arthroplasty: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised controlled trial included 22 patients undergoing primary TKA"
      },
      "Participants": {
        "score": 2,
        "evidence": "22 patients undergoing primary TKA, conducted at a single orthopedic center"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Group 1 (n=11) received 1 g cefazolin systemically... Group 2 (n=11) received 1 g cefazolin intraosseously"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study compares tissue concentrations of cefazolin achieved via systemic versus regional intraosseous administration"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "antibiotic concentrations were measured using high-performance liquid chromatography"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "22 patients undergoing primary TKA"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Group 1 (n=11)... Group 2 (n=11)"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The mean tissue concentration of cefazolin in subcutaneous fat was 186 ug/g in the intraosseous group and 11 ug/g in the systemic group"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration and funding details were not provided"
      },
      "Funding": {
        "score": 0,
        "evidence": "Trial registration and funding details were not provided"
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}